A computational modeling framework for pre-clinical evaluation of cardiac mapping systems

被引:0
|
作者
Galappaththige, Suran [1 ]
Pathmanathan, Pras [1 ]
Gray, Richard A. [1 ]
机构
[1] FDA, Ctr Devices & Radiol Hlth, Div Biomed Phys, Off Sci & Engn Labs, Silver Spring, MD 20993 USA
关键词
cardiac mapping; computational modeling; cardiac electrophysiology; arrhythmia; regulatory science; ATRIAL-FIBRILLATION; CATHETER ABLATION; CHALLENGES; MECHANISMS; PHASE;
D O I
10.3389/fphys.2023.1074527
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
There are a variety of difficulties in evaluating clinical cardiac mapping systems, most notably the inability to record the transmembrane potential throughout the entire heart during patient procedures which prevents the comparison to a relevant "gold standard". Cardiac mapping systems are comprised of hardware and software elements including sophisticated mathematical algorithms, both of which continue to undergo rapid innovation. The purpose of this study is to develop a computational modeling framework to evaluate the performance of cardiac mapping systems. The framework enables rigorous evaluation of a mapping system's ability to localize and characterize (i.e., focal or reentrant) arrhythmogenic sources in the heart. The main component of our tool is a library of computer simulations of various dynamic patterns throughout the entire heart in which the type and location of the arrhythmogenic sources are known. Our framework allows for performance evaluation for various electrode configurations, heart geometries, arrhythmias, and electrogram noise levels and involves blind comparison of mapping systems against a "silver standard" comprised of computer simulations in which the precise transmembrane potential patterns throughout the heart are known. A feasibility study was performed using simulations of patterns in the human left atria and three hypothetical virtual catheter electrode arrays. Activation times (AcT) and patterns (AcP) were computed for three virtual electrode arrays: two basket arrays with good and poor contact and one high-resolution grid with uniform spacing. The average root mean squared difference of AcTs of electrograms and those of the nearest endocardial action potential was less than 1 ms and therefore appears to be a poor performance metric. In an effort to standardize performance evaluation of mapping systems a novel performance metric is introduced based on the number of AcPs identified correctly and those considered spurious as well as misclassifications of arrhythmia type; spatial and temporal localization accuracy of correctly identified patterns was also quantified. This approach provides a rigorous quantitative analysis of cardiac mapping system performance. Proof of concept of this computational evaluation framework suggests that it could help safeguard that mapping systems perform as expected as well as provide estimates of system accuracy.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Cardiac safety implications of hNav1.5 blockade and a framework for pre-clinical evaluation
    Erdemli, Guel
    Kim, Albert M.
    Ju, Haisong
    Springer, Clayton
    Penland, Robert C.
    Hoffmann, Peter K.
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [2] High resolution optical mapping of cardiac electrophysiology in pre-clinical models
    O'Shea, Christopher
    Winter, James
    Kabir, S. Nashitha
    O'Reilly, Molly
    Wells, Simon P.
    Baines, Olivia
    Sommerfeld, Laura C.
    Correia, Joao
    Lei, Ming
    Kirchhof, Paulus
    Holmes, Andrew P.
    Fabritz, Larissa
    Rajpoot, Kashif
    Pavlovic, Davor
    SCIENTIFIC DATA, 2022, 9 (01)
  • [3] High resolution optical mapping of cardiac electrophysiology in pre-clinical models
    Christopher O’Shea
    James Winter
    S. Nashitha Kabir
    Molly O’Reilly
    Simon P Wells
    Olivia Baines
    Laura C. Sommerfeld
    Joao Correia
    Ming Lei
    Paulus Kirchhof
    Andrew P. Holmes
    Larissa Fabritz
    Kashif Rajpoot
    Davor Pavlovic
    Scientific Data, 9
  • [4] COMPARISON OF 3 PRE-CLINICAL TECHNIQUE EVALUATION SYSTEMS
    SAUSEN, RE
    GLADWIN, SC
    HUTTON, JG
    JOURNAL OF DENTAL RESEARCH, 1980, 59 : 337 - 337
  • [5] MOXALACTAM - PRE-CLINICAL EVALUATION
    CHABBERT, YA
    SEMAINE DES HOPITAUX, 1983, 59 (26): : 1943 - 1946
  • [6] Pre-clinical modeling of cutaneous melanoma
    Rebecca, Vito W.
    Somasundaram, Rajasekharan
    Herlyn, Meenhard
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [7] Pre-clinical modeling of cutaneous melanoma
    Vito W. Rebecca
    Rajasekharan Somasundaram
    Meenhard Herlyn
    Nature Communications, 11
  • [8] Publisher Correction: High resolution optical mapping of cardiac electrophysiology in pre-clinical models
    Christopher O’Shea
    James Winter
    S. Nashitha Kabir
    Molly O’Reilly
    Simon P. Wells
    Olivia Baines
    Laura C. Sommerfeld
    Joao Correia
    Ming Lei
    Paulus Kirchhof
    Andrew P. Holmes
    Larissa Fabritz
    Kashif Rajpoot
    Davor Pavlovic
    Scientific Data, 11
  • [9] Pre-clinical and clinical experience of telmisartan in cardiac remodelling
    Verdecchia, P
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2005, 33 : 12A - 20A
  • [10] Pre-clinical in vitro evaluation of fluoroquinolones
    Dalhoff, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 4 - 4